Symphony Intrinsic Value
SYMPHONY • Consumer Goods
Current Stock Price
₹719.15
Primary Intrinsic Value
₹276.00
Market Cap
₹1007 Cr
-24.5%
Downside
Median Value
₹542.86
Value Range
₹216 - ₹1798
Assessment
Trading Above Calculated Value
Safety Margin
-32.5%
SYMPHONY Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹276.00 | ₹220.80 - ₹331.20 | -61.6% | EPS: ₹11.04, Sector P/E: 25x |
| Book Value Method | asset | ₹1358.93 | ₹1223.04 - ₹1494.82 | +89.0% | Book Value/Share: ₹543.57, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹754.29 | ₹678.86 - ₹829.72 | +4.9% | Revenue/Share: ₹502.86, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹1062.86 | ₹956.57 - ₹1169.15 | +47.8% | EBITDA: ₹124.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹1797.88 | ₹1438.30 - ₹2157.46 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹215.74 | ₹194.17 - ₹237.31 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹215.74 | ₹194.17 - ₹237.31 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹542.86 | ₹488.57 - ₹597.15 | -24.5% | ROE: 10.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹367.45 | ₹330.70 - ₹404.19 | -48.9% | EPS: ₹11.04, BVPS: ₹543.57 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
SYMPHONY Intrinsic Value Analysis
What is the intrinsic value of SYMPHONY?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Symphony (SYMPHONY) is ₹542.86 (median value). With the current market price of ₹719.15, this represents a -24.5% variance from our estimated fair value.
The valuation range spans from ₹215.74 to ₹1797.88, indicating ₹215.74 - ₹1797.88.
Is SYMPHONY undervalued or overvalued?
Based on our multi-method analysis, Symphony (SYMPHONY) appears to be trading above calculated value by approximately 24.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 22.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Symphony
Additional stock information and data for SYMPHONY
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹259 Cr | ₹239 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹162 Cr | ₹162 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹125 Cr | ₹119 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹57 Cr | ₹57 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹89 Cr | ₹63 Cr | Positive Free Cash Flow | 8/10 |